Latest filing published 02 Oct 2026 for Colgate Palmolive Co, €21k. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by John P. Bilbrey span 4 companies, the busiest being Colgate Palmolive Co, Olaplex Holdings, Inc. and Elanco Animal Health Inc. Over a trading history stretching from 4 January 2016 to 1 October 2026, the count stands at 52 filings.
Every open-market trade on record is a purchase: 7 purchases worth €826k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 39 share grants and 4 option exercises.
The median purchase comes to €97k. 1 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 2 October 2026, the filings show a share grant worth €21k in Colgate Palmolive Co. The last purchase on record was published on 19 November 2024, which is 698 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 52 declarations